Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −4.0% | +11.7% | −15.8% | +3.6% | +17.2% | +72.1% | — | +38.2% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$53 of every $1,000 in IBRN is Biogen
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | BIIBBiogen | Healthcare | 5.33% | $533.12 | 1,826 | $457K |
| 2 | NBIXNeurocrine Biosciences | Healthcare | 5.09% | $509.04 | 2,578 | $437K |
| 3 | EWTXEdgewise Therapeutics | Healthcare | 4.96% | $496.38 | 9,294 | $426K |
| 4 | ALKSAlkermes | Healthcare | 4.75% | $475.10 | 8,676 | $408K |
| 5 | ARGXArgenx SE | Healthcare | 4.43% | $442.67 | 387 | $380K |
| 6 | PRAXPraxis Precision Medicines | Healthcare | 4.30% | $430.41 | 1,137 | $369K |
| 7 | PTCTPTC Therapeutics | Healthcare | 4.29% | $428.87 | 5,807 | $368K |
| 8 | AXGNAxogen | Healthcare | 4.28% | $427.62 | 6,622 | $367K |
| 9 | DNTHDianthus Therapeutics | Healthcare | 3.98% | $397.87 | 3,691 | $341K |
| 10 | 326030.KSSK Biopharmaceuticals | Healthcare | 3.80% | $380.36 | 4,956 | $326K |
| 11 | SRRKScholar Rock | Healthcare | 3.65% | $364.58 | 7,247 | $313K |
| 12 | HLUN-B.COH. Lundbeck | Healthcare | 3.45% | $344.73 | 34K | $296K |
| 13 | DYNDyne Therapeutics | Healthcare | 3.27% | $327.13 | 16K | $281K |
| 14 | XENEXenon Pharmaceuticals | Healthcare | 3.21% | $320.97 | 6,717 | $275K |
| 15 | ACADAcadia Pharmaceuticals | Healthcare | 3.03% | $303.27 | 14K | $260K |
of the $113B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | BIIB | Biogen | 5.33% |
| 2 | NBIX | Neurocrine Biosciences | 5.09% |
| 3 | EWTX | Edgewise Therapeutics | 4.96% |
| 4 | ALKS | Alkermes | 4.75% |
| 5 | ARGX | Argenx SE | 4.43% |
| 6 | PRAX | Praxis Precision Medicines | 4.30% |
| 7 | PTCT | PTC Therapeutics | 4.29% |
| 8 | AXGN | Axogen | 4.28% |
| 9 | DNTH | Dianthus Therapeutics | 3.98% |
| 10 | 326030.KS | SK Biopharmaceuticals | 3.80% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 16, 2025 | Dec 19, 2025 | $0.32 |
| Dec 17, 2024 | Dec 20, 2024 | $0.10 |
| Dec 20, 2023 | Dec 27, 2023 | $0.0063 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0082 |